| Person Name | Explanation |
|---|---|
| PETER JANSSEN | |
| LORRAINE JANSSEN |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 50,000 SHRS AMERICAN BIOGENETIC SCI. | ||
| 3,000 SHRS CHROMATICS COLOR | 30,000 | |
| 1,500 SHRS OPKO HEALTH | 11,063 | 5,505 |
| 100 SHRS ACCESS PHARMACEUTICALS | 472,221 | 248 |
| 200 SHRS PHARMOS CORP. - NEW | 4,375 | 18 |
| 250 SHRS AMERICAN BIOG. SCI. NEW RES | 87,500 | 77 |
| Description | Amount |
|---|---|
| NON EXEMPT EXPENSES | 13,610 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| BANK FEES & OTHER | 9 | 9 | 9 | |
| ADVERTISING | 125 | 125 | 125 | |
| ACCOUNTING | 750 | 750 | 750 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 35 | 35 | 35 |